miR-335-5p 通过MARCH8抑制EMT和PI3K/AKT通路
Arjumand Bano1, Geetika Suyal1,2, Anoop Saraya3
1University School of Biotechnology, Guru Gobind Singh Indraprastha University, Sector-16(C), Dwarka, Delhi, 110078 India.
Indian journal of clinical biochemistry : IJCB
|March 24, 2025
概括
这项研究表明,microRNA-335-5p调节MARCH8的表达,影响关键的癌症途径. 这一发现揭示了食道癌进展的新机制,涉及miR-335-5p/MARCH8轴.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 翻译后修改 翻译后修改
背景情况:
- 乌比基化通过翻译后修饰来调节蛋白质稳定性.
- 包括MARCH8在内的与膜相关的RING-CH (MARCH) E3酶参与了癌症放松调控.
- 关于MARCH8参与癌症的确切机制在很大程度上仍未被描述.
研究的目的:
- 研究miR-335-5p/MARCH8轴在食道癌中的调节作用.
- 阐明这一轴对PI3K/AKT和上皮层-半细胞转换 (EMT) 途径的影响.
主要方法:
- 针对MARCH8.8的微RNAs的in-silico预测
- 实时PCR用于评估患者组织中的miR-335-5p和MARCH8表达.
- 路西法酶测定和西部斑分析以确认食道癌细胞的直接调节和途径调节.
主要成果:
- 确定miR-335-5p是MARCH8表达的关键调节者.
- 在食道癌组织中观察到miR-335-5p和MARCH8之间的反相关性.
- miR-335-5p转染显著降低了MARCH8表达,并抑制了PI3K/AKT和EMT通路.
结论:
- 这项研究确立了miR-335-5p作为食道癌症中MARCH8的直接调节者.
- 该miR-335-5p/MARCH8轴在调节PI3K/AKT和EMT信号方面发挥着至关重要的作用.
- 这个轴代表了食道癌症治疗的潜在治疗点.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


